In addition, survival analysis based on expression of the OSM downstream signaling components ACTA2, MMP1, CCL2 as identified by GeneGO analysis, showed that high expression of these genes related to shorter overall survival time (Fig. 6C) in patients with TP53- mutant HNSCC. Here, CCL2 is linked to head and neck squamous cell carcinoma.